Entera Bio (ENTX) Share-based Compensation (2019 - 2026)

Entera Bio (ENTX) has reported Share-based Compensation for 8 consecutive years, with $672000.0 the latest figure, recorded in Q1 2026.

• Quarterly Share-based Compensation rose 11.26% year-over-year to $672000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 4.53% YoY) and the FY2025 annual result came in at $2.8 million, up 7.59% from the prior year.
• Share-based Compensation eased to $672000.0 in Q1 2026 per ENTX's latest filing, from $710000.0 in the prior quarter.
• Over the last five years, Share-based Compensation for ENTX reached as high as $964000.0 in Q1 2022 and fell as low as $110000.0 in Q3 2022.
• A 5-year average of $583176.5 and a median of $566000.0 in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation plunged 82.48% — and 2023, when it soared 248.18%.
• Year by year, Share-based Compensation stood at $477000.0 in 2022, then sank by 33.33% to $318000.0 in 2023, then soared by 77.99% to $566000.0 in 2024, then increased by 25.44% to $710000.0 in 2025, then decreased by 5.35% to $672000.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $672000.0, $710000.0, and $927000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.